- Wedbush boosted the price target for Starbucks Corporation SBUX from $88 to $101. Starbucks shares rose 0.4% to $100.55 in pre-market trading.
- Needham boosted Docusign Inc DOCU price target from $240 to $275. Docusign shares gained 5.2% to $243.05 in pre-market trading.
- Stephens & Co. raised the price target on NCR Corporation NCR from $30 to $39. NCR shares rose 3.8% to close at $31.33 on Thursday.
- Barclays lifted the price target for Chemours Co CC from $26 to $28. Chemours shares fell 0.4% to $25.58 in pre-market trading.
- KeyBanc boosted the price target on Cooper Companies Inc COO from $349 to $367. Cooper Companies shares rose 0.1% to $338.00 in pre-market trading.
- HC Wainwright & Co. raised TRACON Pharmaceuticals Inc TCON price target from $7 to $12. TRACON Pharmaceuticals shares fell 2.1% to close at $9.15 on Thursday.
- SVB Leerink raised BridgeBio Pharma Inc BBIO price target from $39 to $44. BridgeBio Pharma shares rose 3.4% to close at $50.51 on Thursday.
- Chardan Capital boosted the price target for Mesoblast limited MESO from $5.5 to $7.5. Mesoblast shares fell 6.3% to $14.75 in pre-market trading.
- Mizuho lifted SAGE Therapeutics Inc SAGE price target from $77 to $81. SAGE Therapeutics shares rose 2.6% to $71.70 in pre-market trading.
- KeyBanc lifted price target for Phreesia Inc PHR from $37 to $50. Phreesia shares rose 2.1% to close at $44.92 on Thursday.
Loading...
Loading...
BBIOBridgeBio Pharma Inc
$33.52-0.65%
Edge Rankings
Momentum
87.54
Growth
-
Quality
-
Value
6.94
Price Trend
Short
Medium
Long
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in